{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:21:35Z","timestamp":1772119295200,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2011,4,11]],"date-time":"2011-04-11T00:00:00Z","timestamp":1302480000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s00392-011-0318-z","type":"journal-article","created":{"date-parts":[[2011,4,11]],"date-time":"2011-04-11T21:16:57Z","timestamp":1302556617000},"page":"879-885","source":"Crossref","is-referenced-by-count":18,"title":["Soluble TWEAK predicts hemodynamic impairment and functional capacity in patients with pulmonary arterial hypertension"],"prefix":"10.1007","volume":"100","author":[{"given":"Arthur","family":"Filusch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Zelniker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Baumg\u00e4rtner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Eschricht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Frey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo A.","family":"Katus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Chorianopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,4,11]]},"reference":[{"key":"318_CR1","doi-asserted-by":"crossref","first-page":"32401","DOI":"10.1074\/jbc.272.51.32401","volume":"272","author":"Y Chicheportiche","year":"1997","unstructured":"Chicheportiche Y, Bourdon PR, Xu H, Hsu YM, Scott H, Hession C, Garcia I, Browning JL (1997) TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem 272:32401\u201332410","journal-title":"J Biol Chem"},{"key":"318_CR2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrd2488","volume":"7","author":"JA Winkles","year":"2008","unstructured":"Winkles JA (2008) The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting. Nat Rev Drug Discov 7:411\u2013425","journal-title":"Nat Rev Drug Discov"},{"key":"318_CR3","doi-asserted-by":"crossref","first-page":"8183","DOI":"10.4049\/jimmunol.178.12.8183","volume":"178","author":"LC Bover","year":"2007","unstructured":"Bover LC, Card\u00f3-Vila M, Kuniyasu A, Sun J, Rangel R, Takeya M, Aggarwal BB, Arap W, Pasqualini R (2007) A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications. J Immunol 178:8183\u20138194","journal-title":"J Immunol"},{"key":"318_CR4","doi-asserted-by":"crossref","first-page":"15000","DOI":"10.1074\/jbc.M608668200","volume":"282","author":"C Dogra","year":"2007","unstructured":"Dogra C, Hall SL, Wedhas N, Linkhart TA, Kumar A (2007) Fibroblast growth factor inducible 14 (Fn14) is required for the expression of myogenic regulatory factors and differentiation of myoblasts into myotubes. Evidence for TWEAK-independent functions of Fn14 during myogenesis. J Biol Chem 282:15000\u201315010","journal-title":"J Biol Chem"},{"key":"318_CR5","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1093\/eurjhf\/hfp139","volume":"11","author":"E Chorianopoulos","year":"2009","unstructured":"Chorianopoulos E, Rosenberg M, Zugck C, Wolf J, Katus HA, Frey N (2009) Decreased soluble TWEAK levels predict and adverse prognosis in patients with chronic stable heart failure. Eur J Heart Fail 11:1050\u20131056","journal-title":"Eur J Heart Fail"},{"key":"318_CR6","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.atherosclerosis.2010.02.016","volume":"211","author":"E Chorianopoulos","year":"2010","unstructured":"Chorianopoulos E, Jarr K, Steen H, Giannitsis E, Frey N, Katus HA (2010) Soluble TWEAK is markedly upregulated in patients with ST-elevation myocardial infarction and related to an adverse short-term outcome. Atherosclerosis 211:322\u2013326","journal-title":"Atherosclerosis"},{"issue":"2","key":"318_CR7","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.atherosclerosis.2010.08.061","volume":"213","author":"B Richter","year":"2010","unstructured":"Richter B, Rychli K, Hohensinner PJ, Berger R, M\u00f6rtl D, Neuhold S, Zorn G, Huber K, Maurer G, Wojta J, Pacher R, H\u00fclsmann M, Niessner A (2010) Differences in the predictive value of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in advanced ischemic and non-ischemic heart failure. Atherosclerosis 213(2):545\u2013548","journal-title":"Atherosclerosis"},{"key":"318_CR8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00395-009-0046-y","volume":"105","author":"E Chorianopoulos","year":"2010","unstructured":"Chorianopoulos E, Heger T, Lutz M, Frank D, Bea F, Katus HA, Frey N (2010) FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA\/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK. Basic Res Cardiol 105:301\u2013313","journal-title":"Basic Res Cardiol"},{"key":"318_CR9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1748-1716.2010.02080.x","volume":"199","author":"E Mustonen","year":"2010","unstructured":"Mustonen E, S\u00e4kkinen H, Tokola H, Isopoussu E, Aro J, Leskinen H, Ruskoaho H, Rys\u00e4 J (2010) Tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14 during cardiac remodelling in rats. Acta Physiol (Oxf) 199:11\u201322","journal-title":"Acta Physiol (Oxf)"},{"key":"318_CR10","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1161\/CIRCULATIONAHA.108.837286","volume":"119","author":"M Jain","year":"2009","unstructured":"Jain M, Jakubowski A, Cui L, Shi J, Su L, Bauer M, Guan J, Lim CC, Naito Y, Thompson JS, Sam F, Ambrose C, Parr M, Crowell T, Lincecum JM, Wang MZ, Hsu YM, Zheng TS, Michaelson JS, Liao R, Burkly LCA (2009) Novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failure. Circulation 119:2058\u20132068","journal-title":"Circulation"},{"key":"318_CR11","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1161\/ATVBAHA.109.194852","volume":"29","author":"B Mu\u00f1oz-Garc\u00eda","year":"2009","unstructured":"Mu\u00f1oz-Garc\u00eda B, Moreno JA, L\u00f3pez-Franco O, Sanz AB, Mart\u00edn-Ventura JL, Blanco J, Jakubowski A, Burkly LC, Ortiz A, Egido J, Blanco-Colio LM (2009) Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) enhances vascular and renal damage induced by hyperlipidemic diet in ApoE-knockout mice. Arterioscler Thromb Vasc Biol 29:2061\u20132068","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"318_CR12","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1161\/ATVBAHA.109.195040","volume":"29","author":"K Schapira","year":"2009","unstructured":"Schapira K, Burkly LC, Zheng TS, Wu P, Groeneweg M, Rousch M, Kockx MM, Daemen MJ, Heeneman S (2009) Fn14-Fc fusion protein regulates atherosclerosis in ApoE-\/- mice and inhibits macrophage lipid uptake in vitro. Arterioscler Thromb Vasc Biol 29:2021\u20132027","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"318_CR13","doi-asserted-by":"crossref","unstructured":"Gali\u00e8 N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G; ESC Committee for Practice Guidelines (CPG), Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T, McGregor K, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas P, Widimsky P; Document Reviewers, Sechtem U, Al Attar N, Andreotti F, Aschermann M, Asteggiano R, Benza R, Berger R, Bonnet D, Delcroix M, Howard L, Kitsiou AN, Lang I, Maggioni A, Nielsen-Kudsk JE, Park M, Perrone-Filardi P, Price S, Domenech MT, Vonk-Noordegraaf A, Zamorano JL (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 30:2493\u20132537","DOI":"10.1093\/eurheartj\/ehp297"},{"key":"318_CR14","first-page":"A713","volume":"175","author":"E Gabbay","year":"2007","unstructured":"Gabbay E, Yeow W, Playford D (2007) Pulmonary arterial hypertension (PAH) is an uncommon cause of pulmonary hypertension (PH) in an unselected population: the Armadale echocardiography study. Am J Resp Crit Care Med 175:A713","journal-title":"Am J Resp Crit Care Med"},{"key":"318_CR15","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","volume":"54","author":"G Simonneau","year":"2009","unstructured":"Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing ZC, Krowka MJ, Langleben D, Nakanishi N, Souza R (2009) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 54:S43\u2013S54","journal-title":"J Am Coll Cardiol"},{"key":"318_CR16","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1373\/clinchem.2009.129411","volume":"55","author":"C Widera","year":"2009","unstructured":"Widera C, Horn-Wichmann R, Kempf T, Bethmann K, Fiedler B, Sharma S, Lichtinghagen R, Leitolf H, Ivandic B, Katus HA, Giannitsis E, Wollert KC (2009) Circulating concentrations of follistatin-like 1 in healthy individuals and patients with acute coronary syndrome as assessed by an immunoluminometric sandwich assay. Clin Chem 55:1794\u20131800","journal-title":"Clin Chem"},{"key":"318_CR17","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/s00392-008-701-6","volume":"97","author":"J Honold","year":"2008","unstructured":"Honold J, Geiger L, Assmus B, Fischer-Rasokat U, Schaechinger V, Zeiher AM, Spyridopoulos I (2008) The initial slope of the VCO2\/VO2-curve (s1) in cardiopulmonary exercise testing is a strong and independent predictor of outcome in patients with previous myocardial infarction. Clin Res Cardiol 97:882\u2013890","journal-title":"Clin Res Cardiol"},{"key":"318_CR18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1365-2249.1999.00864.x","volume":"116","author":"M Okawa-Takatsuji","year":"1999","unstructured":"Okawa-Takatsuji M, Aotsuka S, Fujinami M, Uwatoko S, Kinoshita M, Sumiya M (1999) Up-regulation of intercellular adhesion molecule-1 (ICAM-1), endothelial leucocyte adhesion molecule-1 (ELAM-1) and class II MHC molecules on pulmonary artery endothelial cells by antibodies against U1-ribonucleoprotein. Clin Exp Immunol 116:174\u2013180","journal-title":"Clin Exp Immunol"},{"key":"318_CR19","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1164\/rccm.200610-1559OC","volume":"176","author":"O Sanchez","year":"2007","unstructured":"Sanchez O, Marcos E, Perros F, Fadel E, Tu L, Humbert M et al (2007) Role of endothelium-derived CC chemokine ligand 2 in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 176:1041\u20131047","journal-title":"Am J Respir Crit Care Med"},{"key":"318_CR20","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1161\/01.ATV.0000258972.10109.ff","volume":"27","author":"LM Blanco-Colio","year":"2007","unstructured":"Blanco-Colio LM, Mart\u00edn-Ventura JL, Mu\u00f1\u00f3z-Garc\u00eda B, Orbe J, P\u00e1ramo JA, Michel JB, Ortiz A, Meilhac O, Egido J (2007) Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosis. Arterioscler Thromb Vasc Biol 27:916\u2013922","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"318_CR21","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.atherosclerosis.2007.10.022","volume":"199","author":"S Kralisch","year":"2008","unstructured":"Kralisch S, Ziegelmeier M, Bachmann A, Seeger J, L\u00f6ssner U, Bl\u00fcher M, Stumvoll M, Fasshauer M (2008) Serum levels of the atherosclerosis biomarker sTWEAK are decreased in type 2 diabetes and end-stage renal disease. Atherosclerosis 199:440\u2013444","journal-title":"Atherosclerosis"},{"key":"318_CR22","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.cell.2005.09.022","volume":"123","author":"H Maecker","year":"2005","unstructured":"Maecker H, Varfolomeev E, Kischkel F, Lawrence D, Le Blanc H, Lee W, Hurst S, Danilenko D, Li J, Filvaroff E, Yang B, Daniel D, Ashkenazi A (2005) TWEAK attenuates the transition from innate to adaptive immunity. Cell 123:931\u2013944","journal-title":"Cell"},{"key":"318_CR23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.atherosclerosis.2009.04.033","volume":"207","author":"JA Moreno","year":"2009","unstructured":"Moreno JA, Mu\u00f1oz-Garc\u00eda B, Mart\u00edn-Ventura JL, Madrigal-Matute J, Orbe J, P\u00e1ramo JA, Ortega L, Egido J, Blanco-Colio LM (2009) The CD163-expressing macrophages recognize and internalize TWEAK: potential consequences in atherosclerosis. Atherosclerosis 207:103\u2013110","journal-title":"Atherosclerosis"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-011-0318-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-011-0318-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-011-0318-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T19:07:51Z","timestamp":1560107271000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-011-0318-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,11]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["318"],"URL":"https:\/\/doi.org\/10.1007\/s00392-011-0318-z","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.10605956.11475054","asserted-by":"object"}]},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,11]]}}}